Status:
COMPLETED
Clarithromycin Resistant Tailored Therapy
Lead Sponsor:
Jin Il Kim
Collaborating Sponsors:
Korean College of Helicobacter and Upper Gastrointestinal Research
Conditions:
Peptic Ulcer
Helicobacter Pylori Infection
Eligibility:
All Genders
20-75 years
Phase:
PHASE4
Brief Summary
1. Back ground Antibiotics resistance of Helicobacter pylori, especially to clarithromycin is one of the main causes of failure of eradication. 23S rRNA point mutation of Helicobacter pylori is associ...
Eligibility Criteria
Inclusion
- 20 - 75 years old
- Peptic ulcer (gastric ulcer, duodenal ulcer)
- Helicobacter pylori positive
Exclusion
- Major comorbidities
- Pregnancy
- History of Helicobacter pylori eradication
- History of gastric surgery or other cancers, except to endoscopic treatment due to gastric lesion
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
924 Patients enrolled
Trial Details
Trial ID
NCT01453036
Start Date
August 1 2011
End Date
June 1 2012
Last Update
September 27 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gastroenterology Clinic
Seoul, Yeouido-dong/Yeongdeungpo-gu, South Korea, 150-713